Rare condition
Insulinoma
7
studies recruiting now
as of 7 Sept 2026
65
studies registered in total
as of 7 Sept 2026
7
countries with a recruiting site
as of 7 Sept 2026
13 May 2026
most recent study posted
among recruiting studies
Recruiting trials
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 7 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Insulinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Insulinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (YY1, MEN1).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).